Aileron Therapeutics is a biopharmaceutical company that develops and commercializes stabilized cell-permeating alpha-helical peptides to address intracellular targets in oncology and other therapeutic areas. The company's product candidate, ALRN-6924, is a cell-permeating peptide that mimics the p53 tumor suppressor protein to disrupt p53's interactions with its endogenous inhibitors, MDMX and MDM2. ALRN-6924 is designed to activate the mechanisms used by p53 in cells with non-mutant, or wild-type, p53 to regulate cell division and progression through the cell replication cycle, programmed death of cancerous cells, or apoptosis, and induction of the immune system to respond against cancer cells.

Air T is a holding company. Through its subsidiaries, the company operates the following industry segments: overnight air cargo, which operates in the air express delivery services industry; ground equipment sales, which manufactures and provides mobile deicers and other equipment products; ground support services, which provides ground support equipment maintenance and facilities maintenance services; commercial aircraft, engines and parts, which provides services including commercial aircraft disassembly/part-out services; and printing equipment and maintenance, which designs, manufactures and sells digital print production equipment and provides maintenance services to commercial customers.

Aldeyra Therapeutics is a biotechnology company engaged in developing and commercializing medicines for patients with immune-mediated diseases. The company's primary product candidate, reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. The company has additional product candidates in development for proliferative vitreoretinopathy and other retinal diseases, autoimmune disease, and cancer. The company has discovered and are developing two additional reactive aldehyde species inhibitors, ADX-103 and ADX-629, for the treatment of retinal disease and autoimmune disease, respectively.

At Home Group is a holding company. Through its subsidiaries, the company is a home decor superstore. The company's product mix includes home furnishings, which consists of accent furniture, furniture, mirrors, patio cushions, rugs and wall art. Accent decor consists of artificial flowers and trees, bath, bedding, candles, garden and outdoor decor, holiday accessories, home organization, pillows, pottery, vases and window treatments. The company operates its stores primarily in the South Central, Southeastern, Mid-Atlantic and Midwestern regions of the U.S. In addition, the company operates a distribution center and warehouse premises in Texas, which services its stores, and a second distribution center in Pennsylvania.

Cerecor is a biopharmaceutical company. The company is building a pipeline of therapies in neurology, pediatric healthcare, and orphan rare diseases. The company's neurology pipeline is led by CERC-301, which is in a Phase I safety study for Neurogenic Orthostatic Hypotension. The company is also developing two other neurological clinical and preclinical stage compounds. The company's pediatric orphan rare disease pipeline is led by CERC-801, CERC-802 and CERC-803. All three of these compounds are preclinical therapies for inherited metabolic disorders known as Congenital Disorders of Glycosylation by means of substrate replacement therapy.

Clearside Biomedical is a biopharmaceutical company developing treatments that restore vision for people with back of the eye diseases. The company's suprachoroidal injection platform is a patented approach for delivering pharmacotherapy to the back of the eye via the suprachoroidal space (SCS). The company's key product candidate, XIPERE, is a proprietary, preservative-free suspension of the corticosteroid triamcinolone acetonide formulated for administration via suprachoroidal injection, for the treatment of macular edema related with uveitis. The company is also developing Axitinib for Suprachoroidal Injection for administration to the SCS as a long-acting therapy for wet age-related macular degeneration.

Continental Resources is an independent crude oil and natural gas company engaged in the exploration, development, and production of crude oil and natural gas mainly in the North, South and East regions of the U.S. The North region consists of properties north of Kansas and west of the Mississippi River and includes North Dakota Bakken, Montana Bakken, and the Red River units. The South region includes all properties south of Nebraska and west of the Mississippi River including various plays in the South Central Oklahoma Oil Province and Sooner Trend Anadarko Canadian Kingfisher areas of Oklahoma. The East region is comprised of undeveloped leasehold acreage east of the Mississippi River.

CytomX Therapeutics is clinical-stage, oncology-focused biopharmaceutical company with a class of investigational antibody therapeutics based on its Probody? technology platform the treatment of cancer. The company uses its platform to create proprietary cancer immunotherapies against clinically-validated targets. The company's two programs, CX-072, a wholly owned PD-L1-targeting Probody therapeutic and CX-2009, wholly owned CD166-targeting Probody drug conjugate. Both CX-072 and CX-2009 are part of PROCLAIM (Probody Clinical Assessment in Man), an international umbrella clinical trial program that provides clinical trial sites with access to the company's novel therapies under one central protocol.

Earthstone Energy is an independent oil and gas company engaged in the acquisition and development of oil and gas reserves through activities that include the acquisition, drilling and development of undeveloped leases, asset and corporate acquisitions and mergers. The company's operations are all in the upstream segment of the oil and natural gas industry and all the company's properties are onshore in the U.S. The company's primary assets are located in the Midland Basin of west Texas and the Eagle Ford Trend of south Texas.

Energy Services of America provides contracting services for energy related companies. For the gas industry, the company is engaged in the construction, replacement and repair of natural gas pipelines and storage facilities for utility companies and private natural gas companies. For the oil industry, the company provides services relating to pipeline, storage facilities and plant work. For the power, chemical, and automotive industries, the company provides a range of electrical and mechanical installations and repairs including substation and switchyard services, site preparation, equipment setting, pipe fabrication and installation, packaged buildings, transformers and other ancillary work with regards thereto.

Golub Capital BDC is registered as an externally managed, closed-end, non-diversified management investment company. The company makes investments primarily in one stop (a loan that combines characteristics of first lien senior secured loans and second lien or subordinated loans) and other senior secured loans of middle-market companies that are, in most cases, sponsored by private equity firms. The company's investment objective is to generate existing income and capital appreciation by investing primarily in one stop and other senior secured loans of United States middle-market companies.

Gritstone Oncology is an immuno-oncology company developing tumor-specific cancer immunotherapies to fight multiple cancer types. The company's main immunotherapy product candidate, GRANITE, is for the treatment of common solid tumors, including metastatic non-small cell lung cancer and gastroesophageal, bladder and microsatellite stable, colorectal cancers. The company's second tumor-specific product candidate series, SLATE, contains a fixed cassette with tumor-specific neoantigens that are shared across a subset of cancer patients rather than a cassette different to an individual patient, providing the company with an off-the-shelf alternative to its personalized manufactured product candidate, GRANITE.

Icahn Enterprises is a holding company. Through its subsidiaries, the company is engaged in the following operating businesses: Investment, which is comprised of various private investment funds in which the company has general partner interests and through which the company invests its proprietary capital; Energy, which engages in the petroleum refining and nitrogen fertilizer manufacturing industries through its interests in CVR Refining, LP and CVR Partners, LP; Automotive, which invests in and operates businesses involved in automotive repair and maintenance services; and Food Packaging, which produces cellulosic, fibrous and plastic casings used to prepare and package processed meat products.

Jack Henry & Associates is a provider of information processing solutions for community banks. The company's range of products and services includes processing transactions, automating business processes, and managing information for financial institutions and corporate entities. The company's proprietary solutions are marketed through three primary business brands: Jack Henry Banking, which is a provider of integrated data processing systems; Symitar, which is a provider of data processing solutions for credit unions of various sizes; and ProfitStars, which is a provider of agnostic products and services to financial institutions that are primarily not main customers of the company

Kingsway Financial Services is a holding company. Through its subsidiaries, Co. operates as a merchant bank engaged in the property and casualty insurance business. Co. operates three segments: Insurance Underwriting, which markets automobile insurance products that provide coverage in three main areas: liability, accident benefits and physical damage; Insurance Services, which includes IWS Acquisition Corporation, a licensed motor vehicle service agreement company, and Trinity Warranty Solutions LLC, a provider of warranty products and maintenance support; and Leased Real Estate, which includes Co.'s subsidiary, CMC Industries, Inc., that owns a parcel of real property located in Texas.

Mirum Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. The company's pipeline consists of two clinical-stage product candidates, maralixibat and volixibat, with mechanisms of action that have potential utility across a wide range of orphan liver diseases.

MVB Financial is a financial holding company. Through its subsidiaries, the company provides community banking and mortgage banking. The company's subsidiary, MVB Bank, Inc. (The Bank), provides products and services, including: demand deposit accounts, savings accounts, money market accounts, and certificates of deposit; commercial, consumer, and real estate mortgage loans and lines of credit; cashier's checks; safe deposit rental facilities; and non-deposit investment services. The Bank's financial products and services are provided through its financial service locations and automated teller machines, as well as telephone and internet-based banking through both personal computers and mobile devices.

National Research is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare organizations. The company's portfolio of subscription-based solutions provides information and analysis to healthcare organizations across a range of elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management and brand loyalty. The company partners with clients across the continuum of healthcare services. The company's clients include integrated health systems, post-acute providers and payer organizations.

NeoPhotonics develops, manufactures and sells optoelectronic products that transmit, receive and switch high-speed digital optical signals for Cloud and data center internet content provider and telecom networks. The company focuses on products that operate at speed over distance, for 100 Gigabits per Second (G), 200G, and 400G and above data rates, such as at 600G and 800G. The company produces transmitter and receiver components and modules, as well as switching products, for 100G and beyond transmission over distances of two to 2,000 kilometers. The company integrates transmitter and receiver components into next generation pluggable transceiver modules.

Odonate Therapeutics is a pharmaceutical company focused on the development of therapeutics that improve and extend the lives of patients with cancer. The company's initial focus is on the development of tesetaxel, an investigational, orally administered chemotherapy agent that belongs to a class of drugs known as taxanes, which are used in the treatment of cancer. In patients with metastatic breast cancer, tesetaxel was shown to have single-agent antitumor activity in two multicenter, Phase 2 studies. The company is conducting a multinational, multicenter, randomized, Phase 3 study in patients with locally advanced or metastatic breast cancer, known as CONTESSA.

PBF Energy is a holding company. Through its subsidiaries, the company is engaged as an independent petroleum refiner and supplier of unbranded transportation fuels, heating oil, petrochemical feedstocks, lubricants and other petroleum products in the U.S. The company operates in two business segments: refining, which the company produces a variety of products at each of its refineries such as gasoline, ultra-low-sulfur diesel, heating oil, jet fuel, lubricants, petrochemicals and asphalt; and logistics, which through its PBF Logistics LP subsidiary, the company owns or leases, operates, develops and acquires crude oil and refined petroleum products terminals, pipelines, storage facilities and similar logistics assets.

Pulse Biosciences is a bioelectric medicine company. The company is pursuing regulatory clearance to market CellFX? System (CellFX). The CellFX System utilizes its Nano-Pulse Stimulation? (NPS) technology to treat various applications for which an optimal solution remains unfulfilled. NPS is a proprietary technology that delivers nanosecond duration pulses of high amplitude electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue. The company's CellFX System allows for the adjustment of four key treatment parameters: pulse duration, pulse amplitude, pulse frequency, and the number of pulses, depending on the target tissue, application and desired treatment outcome.

REV Group is a holding company. Through its subsidiaries, the company is a designer, manufacturer and distributor of specialty vehicles and related aftermarket parts and services. The company provides customized vehicle solutions for applications including: essential needs (ambulances, fire apparatus, school buses and municipal transit buses), industrial and commercial (terminal trucks, cut-away buses and sweepers) and consumer leisure (recreational vehicles (RVs), and coaches). The company's segments are: Fire and Emergency, which sells fire apparatus equipment and ambulances; Commercial, which produces buses, terminal trucks and sweepers; and Recreation, which provides motorized and towable RV models.

Ring Energy is an exploration and production company that is engaged in oil and natural gas acquisition, exploration, development and production activities. The company's primary drilling operations target the Central Basin Platform in Andrews County and Gaines County, TX and the Delaware Basin in Reeves County and Culberson County, TX, all of which are part of the Permian Basin. The company principally sell its oil and natural gas production to end users, marketers and other purchasers that have access to nearby pipeline facilities. In areas where there is no practical access to pipelines, oil is trucked to storage facilities.

Roots Corp is a Canada-based retailer within apparel industry. It offers leather goods, athletic wear and accessories. Its products comprise leather bags, handbags, purses, briefcases, footwear, as well as men's and women's clothing, including sweaters, hoodies, sweats, watches, athletic t-shirts, yoga wear, accessories, among others. Also, it offers clothes for children. In addition, the Company creates home design products, such as leather furniture for residential or commercial setting. The Company operates over 100 stores in Canada and in the United States, has partner-operated locations in Taiwan and China, as well as runs online retail business. The Company is majority owned by Searchlight Capital Partners, a private investment firm, which operates across North America and Europe.

TRACON Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of targeted therapeutics for cancer and wet age-related macular degeneration. The company is developing its primary product candidate, TRC105 (carotuximab), an endoglin antibody, for the treatment of multiple solid tumor types in combination with inhibitors of the vascular endothelial growth factor pathway, or in combination with inhibitors of the programmed cell death protein 1 pathway. The company's second clinical stage product oncology candidate is TRC102, a small molecule being developed for the treatment of lung cancer and mesothelioma.

TrueCar is an internet-based information, technology, and communication services company. The company helps consumers by providing information related to what others have paid for a make, model and trim of car in their area and guaranteed savings off the manufacturer's suggested retail price for that make, model and trim, as well as, in instances, price offers on actual vehicle inventory, which it refers to as Vehicle Identification Number-based offers, from its network of TrueCar Certified Dealers. The company's network of TrueCar Certified Dealers consisted mainly of new car franchises, representing various makes of cars, as well as independent dealers selling used vehicles.

United Insurance Holdings is a holding company. Through its subsidiaries, the company is engaged in the residential personal and commercial property and casualty insurance business in the United States. The company's insurance subsidiaries provide personal residential and commercial property and casualty insurance products that protect its policyholders against losses due to damages to structures and their contents. Some of the company's insurance subsidiaries sell policies that protect against liability for accidents as well as property damage. The company's non-insurance subsidiaries support its insurance and investment operations. The company writes in Florida, Connecticut, Georgia, Hawaii, Louisiana, and other various states.